TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
VSTM

Verastem Inc

Healthcare · Biotechnology

7.80$ -4.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VSTM
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 81.2% 61.4% 81.4% 96.6% 98.0% 97.2% 97.8% 91.4% 58.6% 93.9% 97.3% 97.7% 96.0% 93.5% 90.7%
99.4% 35.5% 10.9% 15.1% 34.4% 22.0% 38.7% 91.5% 46.8% 30.0% 43.9% 19.6% 78.8% 52.0% 87.5% 83.2%
– 81.0% 60.9% 80.9% 93.9% 97.5% 96.7% 96.5% 90.1% 52.1% 91.5% 92.3% 92.5% 91.6% 87.5% 83.2%
– 0.1% 0.2% 0.1% 2.4% 0.1% 0.2% – 0.1% 1.7% 0.2% 0.5% 0.0% 0.0% 0.2% 3.6%
– – 0.0% 0.0% 0.0% -0.1% 0.0% 0.0% 0.1% 2.1% 0.0% -92.7% – – 0.0% 0.7%
0.2% 1.2% 0.9% 0.5% 2.9% 1.8% 1.7% 1.0% 0.5% 0.7% 2.0% 0.2% 0.1% – – –
– – 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% – – – – – – – –
– – 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 7.8% 13.8% – – – – – 6.7%
10.2% 121.6% 2.6% 6.2% 10.0% 9.4% 13.6% 35.8% 55.2% 95.1% 25.3% 19.4% 50.1% 61.7% 128.5% 76.8%
10.2% 5.3% 2.6% 6.2% 9.3% 8.9% 13.1% 19.1% 13.4% 20.6% 11.1% 17.1% 22.8% 17.6% 30.5% 29.3%
– – – – – – – 16.5% 2.1% 0.3% 0.4% 0.6% 1.1% 0.6% 1.0% 0.2%
7.7% 3.9% 2.0% 2.2% 3.3% 3.5% 4.9% 10.2% 3.7% 6.7% 1.2% 2.1% 5.2% 4.8% 4.0% 5.1%
– – 0.0% 0.0% 0.0% 0.0% 0.0% 16.5% 41.4% 71.4% 12.3% 0.2% 25.8% 26.8% 40.1% 33.0%
89.8% 93.8% 97.4% 93.8% 90.0% 90.6% 86.4% 64.2% 44.8% 4.9% 74.7% 80.6% 49.9% 38.3% -28.5% 23.2%
– -24.5% -50.0% -70.0% -142.9% -175.9% -281.4% -337.6% -135.5% -361.8% -383.9% -610.8% -775.9% -551.0% -941.1% -472.7%
2.5% 2.9% 1.7% 1.5% 2.2% 2.6% 3.7% 3.6% 2.1% 4.3% 8.3% 13.4% 17.0% 14.7% 35.2% 28.1%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?